BioSpace News Archive

Drug Development

Ardelyx Presents Positive Data at DDW 2023 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Ardelyx, Inc. (Nasdaq: ARDX) today announced that a new analysis from IBSRELA Phase 3 trial, T3MPO-2, was presented in a poster presentation at the 2023 Digestive Disease Week Conference (DDW 2023) that is now underway in Chicago, Illinois.

May 9, 2023
·
6 min read
Business

Corbus Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company, today provided a corporate update and reported financial results for the first quarter of 2023.

May 9, 2023
·
10 min read
Business

Rallybio Reports First Quarter 2023 Financial Results

Rallybio Corporation (Nasdaq: RLYB) today reported financial results for the first quarter ended March 31, 2023 and provided an update on recent program and corporate developments.

May 9, 2023
·
10 min read
Policy

FDA Accepts Application for Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application for Vabysmo® for the treatment of macular edema following retinal vein occlusion.

May 9, 2023
·
10 min read
Business

ERYTECH Provides Business and Financial Update for the First Quarter of 2023

ERYTECH Pharma,aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided a business and financial updatefor thefirst quarter of 2023.

May 9, 2023
·
10 min read
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

On April 22, Neuboron Medical Group, a leading global Accelerator-based Boron Neutron Capture Therapy total solution provider, and Xiamen Humanity Hospital collaborated to co-host the Xiamen BNCT Technology Forum 2023 at the BNCT center in XHH.

May 9, 2023
·
4 min read
Positive Interim Data of BellaSeno’s Clinical Trial with Resorbable Breast and Chest Implants Reported at RACS 2023

BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced positive interim results from two clinical trials of its products sponsored by its Australian subsidiary, BellaSeno Pty.

May 9, 2023
·
4 min read
Business

Novavax Reports First Quarter 2023 Financial Results and Operational Highlights

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced its financial results and operational highlights for the first quarter ended March 31, 2023.

May 9, 2023
·
14 min read
Empower Clinics Provides Corporate Update

EMPOWER CLINICS INC an integrated healthcare company with a developing research and clinical trials divisions announces various corporate updates.

May 9, 2023
·
6 min read
BioMidwest

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week® Annual Meeting

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, presented new data supporting the company’s research and innovation in colorectal cancer during Digestive Disease Week® 2023, May 6-9 in Chicago, Illinois.

May 9, 2023
·
10 min read